These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone. McCambridge J; Gossop M; Beswick T; Best D; Bearn J; Rees S; Strang J Drug Alcohol Depend; 2007 Apr; 88(1):91-5. PubMed ID: 17064857 [TBL] [Abstract][Full Text] [Related]
25. Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone. Negus SS J Pharmacol Exp Ther; 2006 May; 317(2):711-23. PubMed ID: 16456085 [TBL] [Abstract][Full Text] [Related]
26. [Neurochemical basis of ultra rapid opioid detoxication]. Golovko AI; Leont'eva LV; Golovko SI; Zefirov SIu; Konoplin DA; Romanenko OP Vopr Med Khim; 2002; 48(2):154-73. PubMed ID: 12189623 [TBL] [Abstract][Full Text] [Related]
27. [Limited role of naltrexone in the treatment of opiate addiction]. van Brussel GH Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1452-6. PubMed ID: 11503313 [TBL] [Abstract][Full Text] [Related]
28. Alternative strategies of opiate detoxification: evaluation of the so-called ultra-rapid detoxification. Scherbaum N; Klein S; Kaube H; Kienbaum P; Peters J; Gastpar M Pharmacopsychiatry; 1998 Nov; 31(6):205-9. PubMed ID: 9930633 [TBL] [Abstract][Full Text] [Related]
29. Addiction pharmacotherapy 2000: new options, new challenges. Rawson RA; McCann MJ; Hasson AJ; Ling W J Psychoactive Drugs; 2000; 32(4):371-8. PubMed ID: 11210198 [TBL] [Abstract][Full Text] [Related]
31. Medication-assisted treatment of opioid use disorder: review of the evidence and future directions. Connery HS Harv Rev Psychiatry; 2015; 23(2):63-75. PubMed ID: 25747920 [TBL] [Abstract][Full Text] [Related]
32. The naloxone test for opiate dependence. Judson BA; Himmelberger DU; Goldstein A Clin Pharmacol Ther; 1980 Apr; 27(4):492-501. PubMed ID: 7357808 [TBL] [Abstract][Full Text] [Related]
33. Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey. Curcio F; Franco T; Topa M; Baldassarre C; Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):871-4. PubMed ID: 21845796 [TBL] [Abstract][Full Text] [Related]
34. Management of opiate detoxification in jails. Fiscella K; Moore A; Engerman J; Meldrum S J Addict Dis; 2005; 24(1):61-71. PubMed ID: 15774411 [TBL] [Abstract][Full Text] [Related]
35. Neurobiology of addictive behaviors and its relationship to methadone maintenance. Stimmel B; Kreek MJ Mt Sinai J Med; 2000; 67(5-6):375-80. PubMed ID: 11064487 [TBL] [Abstract][Full Text] [Related]
36. Psychosocial factors in outcome in two opiate addiction treatments. Grey C; Osborn E; Reznikoff M J Clin Psychol; 1986 Jan; 42(1):185-9. PubMed ID: 3950006 [TBL] [Abstract][Full Text] [Related]
37. The role of the National Institute on Drug Abuse in the development of naltrexone. Ginzburg HM; Glass WJ J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):4-6. PubMed ID: 6088469 [TBL] [Abstract][Full Text] [Related]
38. Prehospital Naloxone Administration as a Public Health Surveillance Tool: A Retrospective Validation Study. Lindstrom HA; Clemency BM; Snyder R; Consiglio JD; May PR; Moscati RM Prehosp Disaster Med; 2015 Aug; 30(4):385-9. PubMed ID: 26061280 [TBL] [Abstract][Full Text] [Related]
39. The rationale for naltrexone therapy as an alternative to methadone treatment for opiate addiction. Simon DL Conn Med; 1996 Nov; 60(11):683-5. PubMed ID: 8979434 [No Abstract] [Full Text] [Related]
40. [Clonidine-naltrexone: a new technic for the detoxification of opiate addicts]. Oliveros SC; Caballero L; Iruela LM Med Clin (Barc); 1990 Nov; 95(16):627-9. PubMed ID: 2097456 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]